Literature DB >> 25275660

Proportion hyperglycosylated hCG: a new test for discriminating gestational trophoblastic diseases.

Laurence A Cole1.   

Abstract

INTRODUCTION: Hyperglycosylated human chorionic gonadotropin (hCG) is a variant of hCG with large oligosaccharide side chains. Although hCG is produced by syncytiotrophoblast cells, hyperglycosylated hCG marks cytotrophoblast cell. Hyperglycosylated hCG signals placental implantation.
METHODS: Total hCG in serum and urine is measured by the Siemens Immulite hCG pregnancy test; the result is in milli-international unit per milliliter. Hyperglycosylated hCG is determined by the B152 microtiter plate assay; the result is in nanogram per milliliter. Hyperglycosylated hCG results can be converted to milli-international unit per milliliter equivalents by multiplying by 11. The test measures proportion hyperglycosylated hCG, hyperglycosylated hCG / total hCG.
RESULTS: Proportion hyperglycosylated hCG marks cases intent on developing persistent hydatidiform mole (68% detection at 17% false detection). Proportion hyperglycosylated hCG also marks persistent hydatidiform mole (100% detection at 5.1% false detection). Proportion hyperglycosylated hCG distinguishes choriocarcinoma and gestational trophoblastic neoplasm cases, absolutely discriminating aggressive cases and minimally aggressive cases. Proportion hyperglycosylated hCG identifies quiescent gestational trophoblastic disease cases. It recognizes quiescent cases that become persistent disease (100% detection at 0% false positive). DISCUSSION: Proportion hyperglycosylated hCG is an invaluable test for discriminating gestational trophoblastic diseases.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 25275660     DOI: 10.1097/IGC.0000000000000280

Source DB:  PubMed          Journal:  Int J Gynecol Cancer        ISSN: 1048-891X            Impact factor:   3.437


  2 in total

1.  Unbalanced human embryos secrete more hyperglycosylated human chorionic gonadotrophin (hCG-H) than balanced ones.

Authors:  Dimitar Parvanov; Dragomira Nikolova; Rumiana Ganeva; Kristina Nikolova; Magdalena Vasileva; Ivaylo Rangelov; Maria Pancheva; Maria Serafimova; Rada Staneva; Savina Hadjidekova; Fabio Scarpellini; Georgi Stamenov
Journal:  J Assist Reprod Genet       Date:  2020-04-22       Impact factor: 3.412

2.  Insights into the hyperglycosylation of human chorionic gonadotropin revealed by glycomics analysis.

Authors:  Linda Ibeto; Aristotelis Antonopoulos; Paola Grassi; Poh-Choo Pang; Maria Panico; Shabnam Bobdiwala; Maya Al-Memar; Paul Davis; Mark Davis; Julian Norman Taylor; Paula Almeida; Mark R Johnson; Richard Harvey; Tom Bourne; Michael Seckl; Gary Clark; Stuart M Haslam; Anne Dell
Journal:  PLoS One       Date:  2020-02-11       Impact factor: 3.240

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.